Mechanism and repertoire of ASC-mediated gene expression by Hasegawa Mizuho et al.
Mechanism and repertoire of ASC-mediated gene
expression
著者 Hasegawa Mizuho, Imamura Ryu, Motani Kou,
Nishiuchi Takumi, Matsumoto Norihiko,










Mechanism and Repertoire of Apoptosis-Associated Speck-Like Protein 
Containing a Caspase Recruitment Domain-Mediated Gene Expression1
 
Mizuho Hasegawa*2, Ryu Imamura*, Kou Motani*, Takumi Nishiuchi†, Norihiko 
Matsumoto*, Takeshi Kinoshita*, and Takashi Suda*3
 
*Division of Immunology and Molecular Biology, Cancer Research Institute, and 
†Division of Functional Genomics, Advanced Science Research Center, Kanazawa 
University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-0934, Japan 
 
Corresponding Author:  
Takashi Suda, PhD.  
Division of Immunology and Molecular Biology, Cancer Research Institute, Kanazawa 
University, 13-1 Takaramachi, Kanazawa, Ishikawa 920-0934, Japan TEL: 
81-76-265-2736; FAX: 81-76-234-4525; E-mail: sudat@kenroku.kanazawa-u.ac.jp 
 
Running title: Mechanism and repertoire of ASC-mediated gene expression 
 
Keywords: Human, Cell Activation, Gene Regulation 
1 
Abstract 
Apoptosis associated speck-like protein containing a caspase recruitment domain (ASC) 
is an adaptor molecule that mediates inflammatory and apoptotic signals. Although the 
role of ASC in caspase-1-mediated IL-1β and IL-18 maturation is well known, ASC 
also induces NF-κB activation and cytokine gene expression in human cells. Here we 
investigated the molecular mechanism and repertoire of ASC-induced gene expression 
in human cells. We found that the specific activation of ASC induced AP-1 activity, 
which was required for optimal IL8 promoter activity. ASC activation also induced 
STAT3- but not STAT1-, interferon-stimulated gene factor 3-, or NFAT-dependent 
reporter gene expression. The ASC-mediated AP-1 activation was NF-κB-independent 
and primarily cell-autonomous response, while the STAT3 activation required NF-κB 
activation and was mediated by a factor that can act in a paracrine manner. 
ASC-mediated AP-1 activation was inhibited by chemical or protein inhibitors for 
caspase-8, caspase-8-targeting small interfering RNA (siRNA), and p38- and 
JNK-inhibitors, but not by a caspase-1 inhibitor, caspase-9- or FADD 
-dominant-negative mutants, FADD or RICK-targeting siRNAs, or a MEK inhibitor, 
indicating that the ASC-induced AP-1 activation is mediated by caspase-8, p38, and 
JNK, but does not require caspase-1, caspase-9, FADD, RICK, or ERK. DNA 
microarray analyses identified 75 genes that were induced by ASC activation. A large 
proportion of them were related to transcription (23%), inflammation (21%), or cell 
death (16%), indicating that ASC is a potent inducer of inflammatory and cell 
death-related genes. This is the first report of ASC-mediated AP-1 activation and the 
repertoire of genes induced downstream of ASC activation. 
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Introduction 
A caspase recruitment domain (CARD4)-containing protein, apoptosis associated 
speck-like protein containing a CARD (ASC, also called TMS-1), was originally 
identified as a protein that forms large aggregates (called specks) in HL-60 human 
leukemia cells treated with chemotherapeutic agents (1), and as the product of a gene 
that is silenced in cancer cells by DNA methylation (2). Thus, ASC has been implicated 
in apoptosis and tumor suppression. ASC consists of an N-terminal pyrin domain and a 
C-terminal CARD. The pyrin domain and CARD belong to the death domain-fold 
domains, which engage in homophilic protein-protein interactions. In this context, ASC 
resembles FADD, an adaptor protein that recruits caspase-8 to death receptors. In fact, 
ASC has been found to recruit caspase-1 to several members of the nucleotide-binding 
domain and leucine-rich repeats (LRRs)-containing proteins (NLRs), including 
cryopyrin (also called NLRP3), and to induce caspase-1-mediated IL-1β maturation 
(3-6). Because these NLRs function as cytoplasmic sensors for invading bacteria and 
viruses in cells, and because macrophages from ASC-deficient mice are defective in the 
production of IL-1β upon microbial infection, ASC is considered to be an important 
molecular component of the innate immune system (7-10). 
In terms of the pro-inflammatory activity of ASC, it has been demonstrated that 
ASC by itself or in combination with NLRs including cryopyrin and CARD12 (also 
called NLRC4, IPAF, CLR2.1, and CLAN) induces NF-κB activation when expressed 
in HEK293 cells by genetic reconstitution (3, 11, 12). Consistent with this, the 
knockdown of ASC expression by RNA interference in human monocytic/macrophagic 
cell lines results in reduced NF-κB activation as well as diminished IL-8 and TNF-α 
production upon Porphyromonas gingivalis infection (13), indicating that ASC plays an 
essential role in the transcriptional activation of inflammatory cytokine genes in human 
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macrophages, although studies involving ASC-deficient mice have indicated that ASC 
is not essential for the expression of cytokine genes and NF-κB activation induced by 
microbial infection in murine macrophages (7, 14, 15).  
To investigate the molecular mechanism of ASC-mediated NF-κB activation, we 
previously developed a chimeric protein (C12N2) consisting of the CARD from 
CARD12 and the nucleotide-binding oligomerization domain (NOD) and LRRs from 
NOD2 (also called NLRC2), a sensor for muramyl dipeptide (MDP) (12). The C12N2 
and ASC-expressing HEK293-derived cell line (MAIL8) produces IL-8 upon MDP 
stimulation in a manner dependent on NF-κB activation. Using this cell line, we 
demonstrated that caspase-8 is required for ASC-mediated NF-κB activation and IL-8 
production (12). 
In this study, to clarify the mechanism of ASC-mediated transcriptional regulation 
of cytokine genes, we explored the ASC-mediated activation of the IL8 promoter and 
transcription factors. In addition, we performed microarray analyses to obtain an 
overview of the genes that are up- or down-regulated upon ASC activation. 
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Materials and Methods 
Reagents 
MDP was purchased from Sigma (Saint Louis, MO), recombinant TNF-α from 
Genzyme (Cambridge, MA). Z-VAD-fluoromethylketone (fmk), z-AAD-chloromethyl-
ketone (cmk) and the MAPK inhibitor set (PD98059, SB202190, SB203580, and 
SB202474) from Calbiochem (La Jolla, CA), and the JNK inhibitor SP600125 from 
Alexis Biochemicals (San Diego, CA).  
 
Cell lines 
The KBG cell line is a HEK293-derived stable transfectant of an NF-κB-GFP reporter 
construct. The MAIL8 cell line is a KBG-derived stable transfectant expressing ASC 
and the FLAG-tagged C12N2 chimeric protein (12). In this study, we used an apoptosis 
resistant subline (MAIL8-102). 
 
Plasmids 
Luciferase reporter plasmids carrying the IL8 promoter (-133-Luc) and its mutants were 
described previously (16, 17). Reporter plasmids carrying TPA-responsive elements 
(TREs) (2xTRE-Luc), acute phase response elements (APREs) (5xAPREsp-Luc), and 
NFAT-binding sites (pNFAT72-Luc) were kindly provided by Dr. Katsuji Yoshioka 
(Kanazawa University Cancer Research Institute, Kanazawa, Japan), Dr. Kouichi 
Nakajima (Osaka City University Medical School, Osaka, Japan), and Dr. Shoichiro 
Miyatake (Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan), 
respectively. Reporter plasmids carrying NF-κB-binding sites (pNF-κB-Luc) were 
purchased from Stratagene (La Jolla, CA), and those carrying interferon-stimulated 
response elements (ISREs) (pISRE-TA-Luc) and gamma-activated sequences (GAS) 
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(pGAS-TA-Luc) were purchased from Clontech (Palo Alto, CA). Expression plasmids 
for a short isoform of caspase-like apoptosis regulatory protein (CLARP-S), a 
constitutive active mutant of CARD12 (CARD12ΔLRR, amino acids 1-457), 
dominant-negative mutants of FADD (amino acids 80-208), caspase-8B (C377S), 
caspase-9 (C287S), and c-Jun (amino acids 123-334), and a proteasome-resistant IκBα 
mutant (S32A, S36A) were described previously (12, 17, 18). 
 
Small interfering RNAs (siRNAs) 
The FADD-, caspase-8-, and RICK-targeting siRNAs were described previously (17). 
ASC-targeting siRNA and control siRNA were purchased from Dharmacon (Chicago, 
IL; si-GENOM D-004378-03 and D-001210-05, respectively) or Invitrogen (Carlsbad, 
CA; Stealth Select RNAi HSS147064 and Stealth RNAi Negative Control Low GC 
Duplex, respectively). MAIL8 cells were transfected with double stranded siRNA 
using Lipofectamine 2000 or RNAiMAX (Invitrogen) according to the manufacturer’s 
protocol. In some experiments, cells were transfected with reporter plasmids using 
linear polyethyleneimine 12 h later. Forty-eight hours after the initial transfection, the 
cells were used for assays unless otherwise specified. 
 
Reporter assay 
Reporter assays were performed as described previously (12). In brief, cells were 
transfected with one of the firefly luciferase reporter plasmids and a control plasmid 
(pRL-TK) constitutively expressing Renilla luciferase, using linear polyethyleneimine. 
The firefly and Renilla luciferase activities were measured 24 hr after the transfection 
using the Dual-Luciferase Reporter Assay System (Promega, Madison, WI). The fold 
induction of luciferase activity = experimental relative luciferase activity / relative 
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luciferase activity of unstimulated cells or vector control; where relative luciferase 
activity = firefly luciferase activity / Renilla luciferase activity.  
 
Western blotting 
Western blotting was carried out as described previously (17, 18). 
 
Measurement of IL-8 
The amount of IL-8 in the culture supernatant was determined using the BD OptEIA Set 
(PharMingen, San Diego, CA).  
 
Measurement of caspase-8 activity 
Caspase-8 activity in cell lysates was determined using caspase-8 fluorometric assay kit 
(MBL, Nagoya, Japan) according to the manufacture protocol. 
 
Microarray analysis 
Microarray analyses were performed according to the Agilent 60-mer Oligo Microarray 
Processing Protocol (Agilent Technologies, Santa Clara, CA). Total RNA was purified 
from MAIL8 or KBG cells cultured with or without 10 ng/ml MDP or TNF-α for 16 h. 
The quality of RNA samples was assessed with the RNA 6000 Nano LabChip Kit using 
Bioanalyzer 2100 (Agilent). Cy3 (for unstimulated samples)- and Cy5 (for stimulated 
samples)-labeled cRNAs were prepared using the Low RNA Input Linear Amplification 
Kit (Agilent). Various mixtures of Cy3- and Cy5-labeled cRNAs were purified using 
the RNeasy RNA purification Kit (Qiagen), and then applied onto the Human 1A (v2) 
22 k Oligo Microarray (Agilent) loaded with 20,173 DNA 60-mers, including those 
from 18,716 human genes. Hybridized and washed arrays were scanned using a 
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microarray scanner G2565BA (Agilent). Microarray images were analyzed with Feature 
Extraction Software v7.5 (Agilent). The significance of the log ratio was assessed by 
computing the most conservative log ratio error and significance value (P value), using 
a standard error propagation algorithm (Agilent) and a universal error model (Rosetta 
Biosoftware, Seattle, WA). Single linkage hierarchical clustering with the Euclidean 
distance metric was performed using MultiExperiment Viewer v4.0 (19). 
 
RT-PCR 
DNA-free RNA was purified from cells using the RNeasy Mini Kit and RNase-free 
DNase Set (Qiagen, Hilden, Germany), and cDNA was prepared using an oligo dT 
primer and Superscript II reverse transcriptase (Invitrogen) according to the 
manufacturer’s protocol. The following primers were used for PCR: TNF forward, 
5’-aaggacaccatgagcactga-3’; reverse, 5’-cgtttgggaaggttggatgtt-3’; IL6 forward, 
5’-ctccaggagcccagctatga-3’; reverse, 5’-cccatgctacatttgccgaa-3’; IL8 forward, 
5’-cagttttgccaaggagtgctaa-3’; reverse, 5’-aacttctccacaaccctctgc-3’; CXCL2 forward, 
5’-aaccgcctgctgagccccat-3’; reverse, 5’-ccttcaggaacagccaccaa-3’; ACTB forward, 
5’-tccctggagaagagctacga-3’; reverse, 5’-aaagccatgccaatctcatc-3’; FOS forward, 
5’-caccgacctgcctgcaagat-3’; reverse, 5’-cagctcgggcagtggcactt-3’; JUNB forward, 
5’-ccacctcccgtttacaccaa-3’; reverse, 5’-gccttgagcgtcttcacctt-3’; JUN forward, 
5’-cgaactgcacagccagaaca-3’; reverse, 5’-tcctgggactccatgtcgat-3’; RELB forward, 
5’-agctacggcgtggacaagaa-3’; reverse, 5’-atcgcggggctacgtggctt-3’; NFKBIA forward, 
5’-ccgagactttcgaggaaata-3’; reverse, 5’-tcagcccctttgcactcataa-3’; NFKBIZ forward, 
5’-gcacaggtgaacaccacaga-3’; reverse, 5’-gagctaatacggtggagctct-3’.  
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Results 
ASC induces AP-1 activation, leading to IL8 promoter activation.  
We previously established HEK293 cell-derived stable cell line (MAIL8) that expresses 
ASC and C12N2, and found that MDP stimulation induces the C12N2-mediated 
oligomerization of ASC and ASC-mediated NF-κB activation, leading to IL-8 
production in this cell line (12). In this response, ASC activation and NF-κB activation 
occur primarily in a same cell, so that the NF-κB activation does not depend on 
externalization or secretion of a certain factor that can act in a paracrine manner. In this 
meaning, the ASC-mediated NF-κB activation is a “cell-autonomous” response. In the 
current study, we first sought to clarify further the molecular mechanisms of 
ASC-mediated IL8 gene expression. Although some sublines of MAIL8 are killed by 
apoptosis upon MDP stimulation (20), many MAIL8 sublines as well as the parental 
HEK293 cell line are resistant to ASC-mediated apoptosis. To avoid the influence of 
cell death on ASC-mediated gene expression, we used an apoptosis-resistant subline 
(MAIL8-102) throughout this study. 
The IL8 promoter region contains three important cis-acting elements for IL8 
gene transcription, namely the NF-κB-, AP-1-, and NF-IL-6-binding sites (16), and IL8 
transcription requires either the combination of the NF-κB- and NF-IL-6- or of the 
NF-κB- and AP-1-binding sites, depending on the type of cell or stimulation (21, 22). 
To determine which elements contribute to the ASC-mediated IL8 promoter activation, 
we used a luciferase reporter gene construct under the control of the minimal essential 
promoter region of the IL8 gene (–133 to +44 bp), which contains all three elements, 
and a series of constructs with a mutation in each of the elements. Consistent with our 
above-described previous findings, ASC activation (induced by MDP stimulation) 
resulted in potent transcriptional activity of the wild-type IL8 promoter in MAIL8 cells, 
9 
and a mutation in the NF-κB-binding site diminished the promoter activity. In addition, 
a mutation in the AP-1- but not the NF-IL-6-binding site caused a severe reduction in 
the ASC-induced IL8 promoter activation (Fig. 1A). Furthermore, a c-Jun 
dominant-negative mutant that inhibits AP-1 activity inhibited the ASC-induced IL8 
promoter activity, whereas the Gal4 DNA-binding domain used as a control did not 
significantly affect the activity (Fig. 1B). Consistent with these results, MDP 
stimulation also induced the expression of an AP-1-reporter construct carrying tandem 
TREs (Fig. 1C). MDP induced the AP-1 activation in HEK293 cells only when ASC 
and C12N2 were expressed simultaneously, but not when these components were 
expressed separately (Fig. 1D), indicating that C12N2 and ASC cooperatively transduce 
the MDP signal into AP-1 activation. Furthermore, knockdown of ASC expression 
using ASC-targeting siRNA abrogated MDP-induced AP-1 activation in MAIL8 cells 
(Fig 1E), confirming that the observed AP-1 activation was mediated by ASC. 
MDP stimulation induced NF-κB and AP-1 activation also in an 
apoptosis-sensitive subline of MAIL8 cells (supplemental Fig. S1),5 indicating that 
these responses are not restricted to apoptosis-resistant sublines. To exclude the possibility 
that ASC could mediate AP-1 activation only in the experimental system using the C12N2 
chimera protein, a LRR-truncated form of CARD12 (CARD12ΔLRR) that can constitutively 
activate ASC was used in place of C12N2 (Fig. 1F). As expected, coexpression of 
CARD12ΔLRR and ASC in HEK293 cells induced AP-1 activation, while either one alone did 
not. These results further support the notion that ASC has a potential to mediate AP-1 
activation. 
Pretreatment with the proteasome inhibitor MG132 and expression of a 
proteasome-resistant mutant of IκBα (IκBα-SR) that inhibits NF-κB activation failed to 
inhibit the MDP-induced AP-1 activation in MAIL8 cells (Fig. 1, G and H). Conversely, 
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the c-Jun dominant-negative mutant failed to inhibit NF-κB activation under the same 
conditions (data not shown). Thus, the MDP-induced NF-κB and AP-1 activation were 
independent of each other.  
To clarify whether MDP induces AP-1 activation in a manner that is 
cell-autonomous or dependent on a factor externalized on the cell surface or in the 
medium, MAIL8 or HEK293 cells were transfected with an AP-1 reporter plasmid, and 
these cell lines were then co-cultured in the presence or absence of MDP. MDP potently 
induced AP-1 activation in MAIL8 cells, but only weak AP-1 activation was observed 
in HEK293 cells under these conditions (Fig. 1I), indicating that MDP induced AP-1 
activation largely in a cell-autonomous manner.  
These data together with our previous results (12) indicate that the 
oligomerization of ASC induced by C12N2 upon MDP stimulation causes the 
cell-autonomous activation of AP-1 and NF-κB independent of each other, and AP-1 
and NF-κB then synergistically induce the transcriptional activity of the IL8 promoter.  
 
ASC-mediated STAT3 activation depends on an externalized factor. 
To investigate whether the activation of ASC induces other inflammatory transcription 
factors, we introduced reporter genes carrying tandem APREs (STAT3-binding sites), 
ISREs (ISGF3-binding sites), GAS (STAT1-binding site), or NFAT-binding sites in 
MAIL8 cells. MDP induced the expression of the APRE reporter gene but not of the 
other reporter genes (Fig. 2A), indicating that the activation of ASC induces STAT3 but 
not STAT1, ISGF3 (a complex of STAT1, STAT2, and IRF9), or NFAT activity. 
Unlike the AP-1 activation, the APRE activation was strongly inhibited by MG132 and 
IκBα-SR (Fig. 2B and data not shown). Furthermore, potent APRE activity was induced 
in HEK293 cells cocultured with MAIL8 cells upon MDP stimulation (Fig. 2C). These 
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results indicate that the ASC-mediated APRE activation was mainly mediated by an 
externalized factor, whose production depended on NF-κB activation. 
 
Caspase-8 is involved in the ASC-mediated AP-1 activation. 
Because caspase-8 plays an important role in ASC-mediated NF-κB activation (12), we 
investigated whether it is also involved in the ASC-mediated AP-1 activation. The 
expression of a caspase-8 dominant-negative mutant or of CLARP (also called FLIP, a 
natural inhibitor protein for caspase-8), but not of dominant-negative mutants of 
caspase-9 or FADD, inhibited the MDP-induced AP-1 activation in MAIL8 cells (Fig. 3, 
A and B). Consistent with this, the knockdown of caspase-8 but not of FADD 
expression by their corresponding siRNAs inhibited this response (Fig. 3C). In addition, 
the knockdown of RICK, which is essential for NOD2-mediated NF-κB activation (23, 
24), did not affect this response. Furthermore, the pan-caspase inhibitor z-VAD-fmk 
and caspase-8 inhibitor z-IETD-fmk inhibited this response, while the caspase-1 
inhibitor Ac-YVAD-cmk and granzyme B inhibitor z-AAD-cmk did not significantly 
affected (Fig. 3D). These results indicate that the catalytic activity of caspase-8 is 
required for the ASC-mediated AP-1 activation, whereas caspase-1, caspase-9, FADD, 
and RICK are not essential for this response.  
 
Role of MAPKs in the ASC-mediated AP-1 activation and IL-8 production  
Different MAPKs play important roles in AP-1 activation in different contexts. 
Therefore, we investigated which MAPKs are activated in MAIL8 cells upon MDP 
stimulation. Western blots using a pair of phosphorylated form-specific and pan-specific 
antibodies against each of the three major types of MAPKs (namely ERK1/2, JNK1/2, 
and p38) indicated that MDP induced phosphorylation of JNK and p38 but not of ERK 
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(Fig. 4A). To determine the contribution of these MAPKs to ASC-mediated AP-1 
activation and IL-8 production, we tested the effects of MAPK- and MAPK 
kinase-inhibitors. Consistent with the observed phosphorylation of JNK and p38, 
inhibitors for these MAPKs (SB202190 and SB203580 for p38, and SP600125 for JNK) 
but not a control substance (SB202474) inhibited the MDP-induced AP-1 activation and 
IL-8 production in MAIL8 cells (Fig. 4, B-E), whereas an inhibitor for MAP/ERK 
kinase (PD98059) failed to inhibit these responses (Fig. 4, C and E). These results 
indicate that JNK and p38 are involved in the ASC-mediated AP-1 activation that is 
required for optimal IL-8 production. None of these inhibitors affected the 
MDP-induced NF-κB activation in MAIL8 cells (Fig. 4F), confirming that 
ASC-mediated NF-κB activation is independent of AP-1 activation. 
 Because ASC-mediated AP-1 activation was dependent on both caspase-8 and 
MAPKs, we investigated how these dependencies inter-related. In MAIL8 cells, 
pan-caspase-inhibitor z-VAD-fmk inhibited MDP-induced JNK phosphorylation (Fig. 
4G), whereas none of MAPK inhibitors inhibited MDP-induced caspase-8 activation 
detected using fluorogenic substrate of caspase-8 (Fig. 4H). These results indicate that 
caspase-8 activation is upstream of MAPK activation. 
 
Profiling of the gene expression induced by ASC activation 
Finally, the profiling of ASC-induced genes by microarray analyses was performed 
{original data sets of microarray analyses are available at CIBEX 
(http://cibex.nig.ac.jp/index.jsp, accession # CBX41) upon publication}. The expression 
of 75 and 23 genes was found to be increased and decreased more than two fold, 
respectively, in MAIL8 cells but not in control KBG cells (HEK293-derived cell line 
stably expressing an NF-κB-GFP reporter construct) upon MDP stimulation 
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(supplemental Table S1). The top 30 genes that were upregulated in MDP-stimulated 
MAIL8 cells but not in MDP-stimulated KGB cells are listed in Table 1. On the other 
hand, 81 genes and 46 genes were, respectively, increased and decreased more than two 
fold, when the KBG cells were stimulated with TNF-α (supplemental Table S2). Cluster 
analysis indicated that some but not all of the genes upregulated by ASC activation 
were also upregulated by TNF-α stimulation (Fig. 5A, See also Table 1 and 
supplemental Table S1). The genes upregulated by both ASC activation and TNF-α 
stimulation included components or inhibitors of NF-κB, and inflammatory cytokines. 
In contrast, the genes that were specifically induced by ASC activation included 
components of AP-1, and stress-related genes. The gene descriptions and/or gene 
ontology terms provided by the manufacturer suggested that about 23%, 21%, and 16% 
of the 75 genes upregulated in MAIL8 after MDP stimulation were related to 
transcription, inflammation, and apoptosis/cell death, respectively (Fig. 5B). The 
induction of mRNAs for inflammatory cytokines (TNF, IL-6, IL-8, and CXCL2) and 
components or regulators of AP-1 and NF-κB (Fos, c-Jun, JunB, RelB, IκBα, and 
IκBζ) was confirmed by RT-PCR analyses (Fig. 5, C and D). MDP-induced expression 
of these mRNAs was markedly reduced when ASC expression was suppressed using 
ASC-targeting siRNA (Fig. 5E), indicating that the MDP-induced gene expression in 




One of the obstacles to investigate the molecular mechanisms of the ASC-induced gene 
expression under physiological conditions is that there is no specific stimulus for ASC. 
Actually, many stimuli for ASC also activate toll-like receptors that have a potential to 
induce a variety of genes. In addition, although macrophages has been used to 
investigate physiological functions of ASC, activation of ASC induces 
caspase-1-mediated IL-1β production, and thus an observed ASC-mediated response 
may be secondary to IL-1β production in this type of cells. To overcome these problems, 
we previously established MAIL8 cells. Importantly, the parental HEK293 cells do not 
express NOD2, and do not respond to MDP. Furthermore, all the MDP-induced 
responses observed so far (i.e. apoptosis, NF-κB activation, and AP-1 activation) in 
MAIL8 cells were ASC dependent (12, 20, and Fig. 1D). In addition, MAIL8 cells as 
well as HEK293 cells express no or little toll-like receptors or caspase-1. Thus, our 
experimental system is more suitable for investigating the molecular mechanism of 
ASC-mediated responses than are more physiological experimental systems in which 
macrophages are stimulated with microbial components or microbes, which can activate 
other pattern-recognition receptors, such as toll-like receptors.  
We previously demonstrated that activation of ASC induces NF-κB activation, 
which is essential for the MDP-induced IL-8 production in MAIL8 cells. Here, we 
showed for the first time that the activation of ASC also induces a cell-autonomous 
AP-1 activation. This response is critical for the MDP-induced IL-8 production in 
MAIL8 cells. Because NF-κB and AP-1 act synergistically to induce expression of a 
variety of genes involved in immune responses, it is likely that the function of ASC to 
mediate coordinated activation of these transcription factors in response to pathogen 
recognition by pattern recognition receptors such as CARD12 and cryopyrin play an 
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important role in the innate immune system. This notion is consistent with a recent 
report demonstrated that ASC plays an important role in NF-κB activation and cytokine 
production in human monocytic/macrophagic cell lines infected by Porphyromonas 
gingivalis (13). In contrast, it has been demonstrated that macrophages isolated from 
ASC-deficient mice produces normal levels of TNF-α and/or IL-6 upon LPS 
stimulation or microbial infection, suggesting that ASC is dispensable for cytokine gene 
expression in mouse macrophages (7, 14, 15). However, the role of ASC in cytokine 
production from other cell types in mice, especially those cells do not express Toll-like 
receptors still remains to be determined. 
The activation of ASC also induced the expression of an APRE-reporter gene, 
indicating STAT3 activation. A cell-autonomous assay (Fig. 2C) revealed that the latter 
response is not cell-autonomous but mediated by a factor that can act in a paracrine 
manner. In addition, this response was suppressed by inhibiting NF-κB (Fig. 2B and 
data not shown) or AP-1 (data not shown), suggesting that the factor is produced in an 
NF-κB- and AP-1-dependent manner. Although IL-6 is a well known inducer for 
STAT3 activation, and IL-6 mRNA was actually induced upon MDP stimulation in 
MAIL8 cells (Table 1 and Fig. 5C), the MDP-induced APRE-reporter gene expression 
in MAIL8 cells was not inhibited by neutralization with an anti-IL-6 mAb, and 
recombinant IL-6 failed to induce the APRE-reporter gene expression in MAIL8 cells 
(data not shown). Thus, some other factor(s) must be responsible for the STAT3 
activation.  
Consistent with the potent activation of three major inflammation-associated 
transcription factors, NF-κB, AP-1, and STAT3, microarray analyses indicated that the 
expression of a number of genes encoding inflammatory cytokines as well as 
components or regulators of NF-κB and AP-1 was upregulated upon ASC activation. 
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These results further supported the idea that ASC plays an important role in 
inflammatory responses through, not only caspase-1 activation, but also the 
transcriptional regulation of a variety of inflammatory factors in human cells. 
Interestingly, a subset of ASC-induced genes, including FOS, JUNB, and JUN, all of 
which encode components of AP-1, was not significantly induced upon TNF-α 
stimulation in MAIL8 cells. One likely reason for TNF-α’s failure to induce some 
ASC-inducible genes is that, unlike ASC activation, TNF-α stimulation induces only 
marginal AP-1 activation in HEK293-derived cell lines, including MAIL8 cells (data 
not shown). The microarray analyses also indicated that ASC induces a number of cell 
death-related genes, including TNF, NRA41 (also called NUR77, Table 1) and BBC3 
(also called PUMA, Fig. 5B). Thus, ASC may be involved in apoptosis not only though 
the activation of caspase-8 but also by inducing the expression of proapoptotic genes. 
Here, we found that the activation of ASC induces AP-1 in a 
caspase-8-dependent manner. Caspase-8 also plays important roles in ASC-mediated 
apoptosis and NF-κB activation (11, 12, 20). Thus, this ASC-caspase-8 axis branches in 
at least three directions. This signal transduction system is strikingly similar to the Fas 
ligand-induced one, which is mediated by the Fas-FADD-caspase-8 axis, in that the 
same three pathways are activated downstream of caspase-8 (17). Nonetheless, FADD 
is not involved in the ASC-mediated responses. Considering the structural similarity of 
FADD and ASC, it is likely that ASC plays an equivalent role to FADD as an adaptor 
protein that acts as a bridge between an upstream molecule (i.e., CARD12) and 
caspase-8. This notion is also supported by our previous finding that endogenous 
caspase-8 colocalizes with ASC upon MDP stimulation in MAIL8 cells (12). ASC 
activation induced a significantly higher level of AP-1 activation than did Fas ligand 
stimulation in MAIL8 cells (data not shown), although caspase-8 plays an essential role 
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in both cases. This is probably because ASC activation induced the phosphorylation of 
both p38 and JNK, which were involved in AP-1 activation (Fig. 5), whereas the Fas 
ligand-induced AP-1 activation solely depends on JNK, and not on p38 (18). Thus, ASC 
and FADD mediate similar signaling pathways, both using caspase-8, but they are not 
exactly the same. This difference between their signals may be explained by the 
different components of the signaling complexes recruited by ASC and FADD. 
In conclusion, our results demonstrate a novel function for ASC in the 
transcriptional regulation of inflammatory and cell-death-related genes in human cells 
and thus provide new insights into the role of ASC in the innate immune system. 
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FIGURE 1. ASC activates the IL8 promoter through AP-1 activation in MAIL8 cells, 
and the ASC-induced AP-1 activation is an NF-κB-independent and cell-autonomous 
response. A, MAIL8 cells were transfected with a reporter plasmid carrying a luciferase 
gene driven by the wild-type IL8 promoter or this promoter mutated at the NF-κB-, 
AP-1-, or NF-IL-6-binding site, and were stimulated with 10 ng/ml MDP or left 
unstimulated during the last 16 h of a 32-h culture. B, MAIL8 cells were co-transfected 
with the wild-type IL8 promoter reporter plasmid and an expression plasmid for a 
dominant-negative mutant of c-Jun (cJun-DN) or the DNA-binding domain of Gal4 
(Gal4-DB), and stimulated as in (A). C, MAIL8 cells were transfected with an AP-1 
reporter plasmid and stimulated as in (A). D, HEK293 cells were transfected with an 
empty vector, or expression vectors for C12N2 and/or ASC as indicated together with 
an AP-1 reporter plasmid, and then stimulated as in (A). E, MAIL8 cells were 
sequentially transfected with siRNA (control or ASC-targeting siRNA) and an AP-1 
reporter plasmid with a 12-h interval. Cells were then stimulated as in (A). Knockdown 
of ASC expression was confirmed by Western Blot. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) serves as an internal control to show equal loading. F, 
HEK293 cells were transfected with an empty vector, or expression vectors for 
CARD12ΔLRR and/or ASC as indicated together with an AP-1 reporter plasmid. AP-1 
activity was determined 24 h after the transfection. G, MAIL8 cells were transfected 
with an AP-1 reporter plasmid and stimulated as in (A), except that the cells were 
pretreated with or without 10 μM MG132 for 1 h before MDP stimulation. H, MAIL8 
cells were co-transfected with the AP-1 reporter plasmid together with either empty 
vector or an expression plasmid for IκBα-SR, and stimulated as in (A). I, MAIL8 cells 
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and HEK293 cells were cultured separately in two wells and transfected with an empty 
vector or an AP-1 reporter plasmid as indicated. Twelve hours later, the cells in the two 
wells were mixed and stimulated with 10 ng/ml MDP or left unstimulated during the 
last 16 h of a further 24-h culture. A-I, IL8 promoter and AP-1 activation was evaluated 
by a luciferase reporter assay. 
 
FIGURE 2. ASC activates APRE-reporter gene expression by a non-cell-autonomous 
mechanism involving NF-κB activation. A, MAIL8 cells were transfected with a 
reporter plasmid carrying APREs, ISREs, GAS, or NFAT-binding sites, and stimulated 
with 10 ng/ml MDP or left unstimulated during the last 16 h of a 32-h culture. The 
observed weak induction of the NFAT reporter gene by MDP was not reproducible. B, 
MAIL8 cells were transfected with the APRE reporter plasmid and stimulated as in (A), 
except that the cells were pretreated with or without 10 μM MG132 for 1 h before MDP 
stimulation. C, MAIL8 cells and HEK293 cells were cultured separately in two wells 
and transfected with an empty vector or an APRE reporter plasmid as indicated. Twelve 
hours later, the cells in the two wells were mixed and stimulated with 10 ng/ml MDP or 
left unstimulated during the last 16 h of a further 24-h culture. A-C, Reporter activity 
was determined by luciferase assay. 
 
FIGURE 3. Caspase-8 is essential for the ASC-induced AP-1 activation. A, MAIL8 
cells were co-transfected with the AP-1 reporter plasmid and an expression plasmid for 
a dominant-negative mutant of caspase-8 or -9 (casp8-DN or casp9-DN), and stimulated 
with 10 ng/ml MDP or left unstimulated during the last 16 h of a 32-h culture. B, 
MAIL8 cells were co-transfected with the AP-1 reporter plasmid and an expression 
plasmid for CLARP-S or a dominant-negative mutant of FADD (FADD-DN), and 
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stimulated as in (A). C, MAIL8 cells were co-transfected with the AP-1 reporter plasmid 
and siRNA targeting caspase-8, FADD, or RICK (10 nM), and stimulated with 10 ng/ml 
MDP or left unstimulated during the last 16 h of a 48-h culture. D, MAIL8 cells were 
transfected with the AP-1 reporter plasmid and stimulated as in (A), except that the cells 
were pretreated with or without Z-VAD-fmk (pan-caspase inhibitor), Ac-YVAD-cmk 
(caspase-1 inhibitor), z-IETD-fmk (caspase-8 inhibitor), or Z-AAD-cmk (granzyme B 
inhibitor) for 1 h before MDP stimulation (20 μM). A-D, AP-1 activation was evaluated 
by a luciferase reporter assay. 
 
FIGURE 4. JNK and p38 activities are required for the ASC-induced AP-1 activation 
and IL-8 production. A, MAIL8 cells were stimulated with 10 ng/ml MDP for the 
indicated periods. The whole-cell lysates were then assayed by western blotting using 
antibodies against phosphorylated or entire JNK1/2, p38 or ERK. Whole-cell lysates 
after UV treatment (500 J/m2) were used as a positive control for phosphorylated 
JNK1/2 and p38. B and C, MAIL8 cells were transfected with the AP-1 reporter 
plasmid and pretreated with the indicated MAPK inhibitors (20 μM) for 1 h, and further 
stimulated with MDP (10 ng/ml) for 16 h. AP-1 activation was evaluated by a luciferase 
reporter assay. D and E, MAIL8 cells were pretreated with the indicated MAPK 
inhibitors (20 μM) for 1 h and further stimulated with MDP (10 ng/ml) for 16 h. The 
amount of IL-8 in the culture supernatant was determined by ELISA. F, MAIL8 cells 
were transfected with the NF-κB reporter plasmid and then treated as in (B). NF-κB 
activity was evaluated by a luciferase reporter assay. G, MAIL8 cells were pretreated 
with the indicated caspase inhibitors (20 μM) for 1 h and further stimulated with MDP 
(10 ng/ml) for 16 h. The whole-cell lysates were then assayed by western blotting using 
antibodies against phosphorylated or entire JNK1/2. H, MAIL8 cells were pretreated 
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with the indicated MAPK or caspase inhibitors (20 μM) for 1 h and further stimulated 
with MDP (10 ng/ml) for 16 h. Cell lysates were then analyzed for caspase-8 activity 
using fluorogenic caspase-8 substrate, IETD-7-amino-4-trifluoromethyl coumarin. RFU, 
relative fluorescent units. B-H, SP600125, JNK inhibitor; PD98059, MEK inhibitor; 
SB202190 and SB203580, p38 inhibitors; SB202474, control substance; z-VAD-fmk, 
pancaspase-inhibitor; z-IETD-fmk, caspase-8 inhibitor. 
 
FIGURE 5. Profiling of the gene expression induced by ASC activation. A, Single 
linkage hierarchical clustering with the Euclidean distance metric of the microarray data 
shown in Table 1 and supplemental Table S1 was performed for those genes that were 
induced more than two-fold by MDP stimulation in MAIL8 cells but not in KBG cells, 
using MultiExperiment Viewer v4.0 (19). B, Sets of genes that are related to 
transcription, inflammation and/or cell death among 75 genes upregulated upon 
ASC-activation. C and D, The total RNA was purified from MAIL8 cells cultured with 
or without 10 ng/ml MDP for the indicated periods in (C) or 12 h in (D). Induction of 
the mRNAs for inflammatory cytokines, AP-1, and NF-κB-related genes was confirmed 
by RT-PCR analyses. E, MAIL8 cells were transfected with control and ASC-targeting 
siRNA twice at a 36-h interval. Cells were then stimulated with or without 10 ng/ml 
MDP during the last 12 h of another 36-h culture. The expression levels of indicated 
genes were then examined by RT-PCR. ACTB, β-actin; NFKBIA, IκBα; NFKBIZ, 
IκBζ. 
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